Maha Radhakrishnan - 04 Jun 2025 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Maha Radhakrishnan
Issuer symbol
CADL
Transactions as of
04 Jun 2025
Net transactions value
$0
Form type
3
Filing time
06 Jun 2025, 16:31:09 UTC
Previous filing
03 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Radhakrishnan Maha Director C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM /s/ Charles Schoch, as Attorney-In-Fact for Maha Radhakrishnan 06 Jun 2025 0002013423

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney; No securities are beneficially owned